CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
Specific oral tolerance inductionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01379651
NCT01379651Phase 2Completed
CompareCT.gov

Specific Oral Tolerance Induction in Children With Severe Egg Allergy: A Randomized Controlled Trial Using a 6 Months Protocol

Ospedale Buon Consiglio Fatebenefratelli·interventional·Posted Jun 23, 2011·Updated Sep 20, 2011

In Brief

A Phase 2 clinical trial evaluating Specific oral tolerance induction for - Egg Hypersensitivity. Completed, enrolled 20 participants across 1 site.

Detailed Summary

To evaluate the efficacy of a 6-month specific oral tolerance induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Conditions- Egg Hypersensitivity
CountriesItaly
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 23, 2011
Enrollment StartJan 1, 2008
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 15.0 years ago

Interventions

Specific oral tolerance inductionother

Specific oral tolerance induction consisted in the administration of increasing amounts of raw emulsion egg